Home / Diabetes In Control (page 784)

Diabetes In Control

Letter from the Editor #512

March 15, 2010 — SPECIAL NEWSFLASH!: Amylin, Lilly and Alkermes received a Complete Response Letter from FDA for Exenatide Once Weekly. New drug to be called BYDUREON (exenatide for extended-release injectable suspension). For more information, click on this link: Exenatide Once Weekly FDA Update *************************************************************** Steve, Andrew and I are …

Read More »

Tamsulosin: Generic Version of Flomax

Boehringer_Ingelheim

Tamsulosin: Generic Version of Flomax This alpha blocker used to treat an enlarged prostate (BPH) is used by many of our patients and generated over 1.9 billion dollars in sales for manufacturer Astellas Pharma, Inc., and their U.S. partner, Boehringer Ingelheim Pharmaceuticals. The drugmaker Ranbaxy is shipping to pharmacies as …

Read More »

Newsflash #512

  Ninety-two Percent of Pre-Diabetes Patients Are Unaware of their Status See this week’s Item #4. FDA Panel Sees User Errors with Insulin Pumps. See this week’s Item #12.  

Read More »

Clarity of Insulin Prescriptions

Clarity of Insulin Prescriptions The drug that has the most prescription errors is insulin. Recently there has been significant interest in the safe use of insulin, partly arising from local awareness of serious insulin related incidents. A key element that has been raised repeatedly is the lack of clarity of …

Read More »

Your Metformin May Smell Fishy

Your Metformin May Smell Fishy: If your metformin smells like the inside of an inner tube or week old fish, you’re not the only one. If you regularly take metformin, one of the oldest and most respected tools in doctors’ anti-diabetes kits, chances are that you don’t detect the unpleasant …

Read More »

Supplementing with Omega-3’s Can Reduce Blood Glucose

Supplementing with Omega-3’s Can Reduce Blood Glucose: In subjects with Type 2 diabetes mellitus, six weeks of supplementation with omega-3 fatty acids reduced the postprandial decrease in macrovascular function relative to placebo, and improved postprandial microvascular function, according to a recent German study In a double blind, placebo-controlled, randomized, crossover …

Read More »

New Trend Developing — “Constant Eating”

New Trend Developing — “Constant Eating”:According to a new study from the University of North Carolina at Chapel Hill, American kids are developing a trend toward “constant eating.” Most kids eat three snacks a day in addition to three meals a day. Researchers feel that this is a contributing factor …

Read More »

A1c’s Over Five Percent Increase Risk for Stroke

Glycated hemoglobin (HbA1c), even at levels considered in the “normal” range, emerged as an independently significant predictor of heart-disease events, stroke, and death over more than a decade in an analysis from the Atherosclerosis Risk in Communities (ARIC) study. The risks of incident diabetes, coronary heart disease events, and death were …

Read More »